LINC00662 Promotes Aggressive Traits by Modulating OCT4 Expression through miR-335-5p in Gallbladder Cancer Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25126740 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Pablo Pérez-Moreno und 7 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Comunicación Celular en Cáncer, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago 7780272, Chile. Hauptthemen laut MEDLINE: Gallbladder Neoplasms, MicroRNAs, RNA, Long Noncoding, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo Nacional de Desarrollo Científico y Tecnológico, The Advanced Research Grant from Research Direction Universidad Autónoma de Chile (DIUAV), Center for Cancer prevention and control (CECAN) ANID/FONDAP.
Abstract (Originalsprache)
Long non-coding RNAs (lncRNAs) are nucleotide sequences that participate in different biological processes and are associated with different pathologies, including cancer. Long intergenic non-protein-coding RNA 662 (LINC00662) has been reported to be involved in different cancers, including colorectal, prostate, and breast cancer. However, its role in gallbladder cancer has not yet been described. In this article, we hypothesize that LINC00662 has an important role in the acquisition of aggressiveness traits such as a stem-like phenotype, invasion, and chemoresistance in gallbladder cancer. Here, we show that LINC00662 is associated with larger tumor size and lymph node metastasis in patients with gallbladder cancer. Furthermore, we show that the overexpression of LINC00662 promotes an increase in CD133+/CD44+ cell populations and the expression of stemness-associated genes. LINC00662 promotes greater invasive capacity and the expression of genes associated with epithelial–mesenchymal transition. In addition, the expression of LINC00662 promotes resistance to cisplatin and 5-fluorouracil, associated with increased expression of chemoresistance-related ATP-binding cassette (ABC) transporters in gallbladder cancer (GBC) cell lines. Finally, we show that the mechanism by which LINC00662 exerts its function is through a decrease in microRNA 335-5p (miR-335-5p) and an increase in octamer-binding transcription factor 4 (OCT4) in GBC cells. Thus, our data allow us to propose LINC00662 as a biomarker of poor prognosis and a potential therapeutic target for patients with GBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Programa de Comunicación Celular en Cáncer, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago 7780272, Chile.
- Institute of Biomedical Sciences, Faculty of Health Sciences, Universidad Autónoma de Chile, Temuco 4810101, Chile.
- Millenium Institute on Immunology and Immunotherapy (IMII), Centro de Prevención y Control de Cancer (CECAN), Department of Pathology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8380000, Chil…
- Centre of Excellence in Translational Medicine (CEMT), Scientific and Technological Bioresource Nucleus (BIOREN), Biomedicine and Translational Research Lab, Universidad de la Frontera, Temuco 4810296, Chile.
- Programa de Biología Celular y Molecular, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.
- Laboratory of Integrative Biology (LIBi), Millennium Institute on Immunology and Immunotherapy (MIII), Center for Excellence in Translational Medicine-Scientific and Technological Bioresource Nucleus (CEMT-BIOREN), Univ…
ORCID-Profile: Ismael Riquelme, Julio C Tapia, Patricia García
Förderung
- Fondo Nacional de Desarrollo Científico y Tecnológico
- The Advanced Research Grant from Research Direction Universidad Autónoma de Chile (DIUAV)
- Center for Cancer prevention and control (CECAN) ANID/FONDAP
- Millenium Institute in Immunology and Immunotherapy, Santiago, Chile (IMII)
- ANID/Fondecyt Post-Doctoral
- Fondecyt
- Research Direction Universidad Autónoma de Chile (DIUAV)
Zitieren
APA
Pérez-Moreno, P., Riquelme, I., Bizama, C., Vergara-Gómez, L., Tapia, J. C., Brebi, P., García, P., & Roa, J. C. (2024). LINC00662 Promotes Aggressive Traits by Modulating OCT4 Expression through miR-335-5p in Gallbladder Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25126740
Vancouver
Pérez-Moreno P, Riquelme I, Bizama C, Vergara-Gómez L, Tapia JC, Brebi P, et al. LINC00662 Promotes Aggressive Traits by Modulating OCT4 Expression through miR-335-5p in Gallbladder Cancer Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25126740
BibTeX
@article{PrezMoreno2024,
author = {Pérez-Moreno, Pablo and Riquelme, Ismael and Bizama, Carolina and Vergara-Gómez, Luis and Tapia, Julio C and Brebi, Priscilla and García, Patricia and Roa, Juan Carlos},
title = {LINC00662 Promotes Aggressive Traits by Modulating OCT4 Expression through miR-335-5p in Gallbladder Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25126740}
}
EUVIMED